Hyperhomocysteinemia and the role of B vitamins in cancer
By: Nadja Plazar and Mihaela Jurdana
Open Access
|May 2010References
- Fassbender K, Orell M, Hennerici M. Plasma Homocyst(e)ine Concentrations in Cerebrovascular Disease.1999; 30: 2224-38.
- Sun CF, Haven TR, Wu TL, Tsao KC, Wu JT. Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker.2002; 321: 55-62.
- Trosseau A. Phlegmasia alba dolens.1865; 3: 654-712.
- Debevec L, Jerič T, Kovač V, Sok M, Bitenc M. The progress in routine management of lung cancer patients. A comparative analysis of an institution in 1996 and 2006.2009; 43: 47-53.
- Rickles FR, Levine M, Edwards RL. Hemostatic alteration in cancer patients.1992; 11: 237-48.
- Smith AD, Kim YI, Refsum H. Is folic acid good for everyone?2008; 87: 517-33.
- Kim YI. Folate: a magic bullet or a double edged sword for colorectal cancer prevention?2006; 55: 1387-89.
- Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.2007; 297: 2351-59.
- Hirsch S, Sanchez H, Albala C, de la Maza MP, Barrera G, Leiva L et al. Colon cancer in Chile before and after the start of the flour fortification program with folic acid.2009; 21: 436-39.
- Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be iluminating important biological principles: a hypothesis.2007; 16: 1325-29.
- Weisberg IS, Park E, Ballman KV, Berger P, Nunn M, Suh DS, et al. Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease.2003; 167: 205-14.
- Voet D, Voet JG.(2nd ed.). New York: John Wiley and Sons, Inc; 1995.
- Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. Homocysteine and risk of cardiovascular disease among postmenopausal women.1999; 281: 1817-21.
- Stanger O, Herrmann W, Pietrzik K, Flower B, Geisel J, Dierkes J, et al. DACHLIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus paper on the regional clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.2003; 41: 1392-403.
- de Bree A, van Dusseldorp M, Brouwer IA, Van het Hof KH, Steegers-Theunissen RPM. Folate intake in Europe: recommended, actual and desired intake.1997; 51: 643-60.
- Herrmann W. The Importance of Hyperhomocysteinemia as a Risk Factor for Diseases: An Overview.2001; 39: 666-74.
- Kachanov DY, Dobrenkov KV, Shamanskaya TV, Abdullaev RT, Inushkina EV, Savkova RF, et al. Solid tumors in young children in moscow Region of Russian Federation.2008; 42: 39-44.
- Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase.2000; 13: 20-33.
- Silaste ML, Rantala M, Sämpi M, Alfthan G, Ato A, Kasänieiemi A. Polimorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women.2001; 131: 2643-47.
- Schriver RC, Beaudet AL, Sly WS, Valle D eds.New York: Mc-Graw-Hill; 1995. p: 1276-1319.
- Heijer den M, Rosendaal FR, Blom HJ, Gerrits WBJ, Bös GMJ. Hyperhomocysteinemia and Venous Thrombosis: A Meta - analysis.1998; 80: 874-7.
- Biasioli S, Schiavon R. Homocysteine as a cardiovascular risk factor.2000; 18: 177-82.
- Ridker PM, Hennekens CH, Selhub J, Mletich JP, MalinoW MR, Tampfer J. Interrelation of hyperhomocysteinemia, factor V Leiden, and risk of venous thromboembolism.1997; 95: 177-82.
- Clarke R, Levington S, Donald A, Johnston C, Refsum H, Stratton I, et al. Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.2001; 8: 396-9.
- Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure.1993; 40: 223-35.
- Pettersson T, Friman C, Abrahamsson L, Nilsson B, Norberg B. Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia.1998; 25: 859-63.
- Bolander-Gouaille C.New York: Springer-Verlag France, Heidelberg; 2001. p. 47-68.
- Fiskerstrand T, Ueland PM, Refsum H. Response of the methionine synthase system to short-term culture with homocysteine and nitrous oxide and its relation to methionine dependence.1997; 72: 301-6.
- Corona G, Toffoli G, Fabris M, Viel A, Zarrelli A, Donada C, et al. Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells.1997; 33: 1284-90.
- Poirier LA. Methyl group deficiency in hepatocarcinogenesis.1994; 26: 185-99.
- Fenech MF, Dreosti IE, Rinaldi JR. Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men.1997; 18: 1329-36.
- Falanga A, Barbui T, Rickles FR, Levine MN. Guidelines for clotting studies in cancer patients. For the Scientific and Standardization Committee of the Subcommittee on Haemostasis and Malignancy International Society of Thrombosis and Haemostasis.1993; 70: 540-42.
- Prandoni P. Venous thromboembolism risk and management in women with cancer and thrombophilia.2005; 2: S28-S34.
- Kessler CM. The Link Between Cancer and Venous Thromboembolism: Review.2009; 32(4 Suppl): S3-S7.
- Dovsak T, Ihan A, Didanovic V, Kansky A, Hren Ihan NI. Influence of surgical treatment and radiotherapy of the advanced intraoral cancers on complete blood count, body mass index, liver enzymes and leukocyte CD64 expression.2009; 43: 282-92.
- Gatt A, Makris A, Cladd H, Burcombe RJ, Smith JM, Cooper P, et al. Hyperhomocysteinemia in women with advanced breast cancer.2007; 29: 421-5.
- Hekim N, Ergen A, Yaylim I, Yilmaz H, Zeybek U, Oztürk O, et al. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.2007; 25: 115-7.
- Jennings E. Folic acid as a cancer- preventing agent.1995; 45: 297-303.
- Al-Awadi F, Yang M, Tan Y, Han Q, Li S, Hoffman RM. Human tumor growth in nude mice is associated with decreased plasma cysteine and homocysteine.2008; 28: 2541-4.
- Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, et al. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia.2003; 21: 3084-91.
- Wu LL, Wu JT. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker.2002; 322: 21-8.
- Wirleitner B, Reider D, Ebner S, Böck G, Widner B, Jaeger M, et al. Monocyte-derived dendritic cells release neopterin.2002; 72: 1148-53.
- Murr C, Bergant A, Widschwendter M, Heim K, Schröcksnadel H, Fuchs D. Neopterin is an independent prognostic variable in females with breast cancer.1999; 45: 1998-2004.
- Murr C, Fuith LC, Widner B, Wirleitner B, Baier-Bitterlich G, Fuchs D. Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?1999; 19(3A): 1721-8.
- Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage.1997; 94: 3290-5.
- Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.1993; 270: 2693-8.
- Freudenheim JL, Graham S, Marshall JR, Haughey BP, Cholewinski S, Wilkinson G. Folate intake and carcinogenesis of the colon and rectum.1991; 20: 368-74.
- Benito E, Stiggelbout A, Bosch FX, Obrador A, Kaldor J, Mulet M, et al. Nutritional factors in colorectal cancer risk: a case-control study in Majorca.1991; 49: 161-67.
- Martinez MA. Diet and cancer prevention: the roles of observation and experimentation.2008; 8: 694-703.
- Perše M, Cerar A. [Physical activity and colorectal cancer]. [Slovenian].2009; 78: 399-405.
- Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices.1975; 15: 617-31.
- Jennings E.Cleveland, Ohio: McGuire & Beckley; 1993.
- Akoglu B, Milovic V, Caspary WF and Faust D. Hyperproliferation of homocysteine-tretaed colon cancer cells is reversed by folate and 5-methyltetrahydrofolate.2004; 43: 93-9.
- James SJ, Cross DR, Miller BJ. Alterations in nucleotide pools in rats fed diets deficient in choline, methionine and/or folic acid.1992; 13: 2471-74.
- Kunz BA. Mutagenesis and deoxyribonucleotide pool imbalance.1988; 200: 133-47.
- Duthie SJ, Narayanan S, Brand GM, Pirie L, Grant G. Impact of folate deficiency on DNA stability.2002; 132(8 Suppl): 2444S-9S.
- Kim YI, Shirwadkar S, Choi SW, Puchyr M, Wang Y, Mason JB. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon.2000; 119: 151-61.
- Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL, Rosner BA, Colditz GA, et al. A prospective study of folate intake and the risk of breast cancer.1999; 281: 1632-7.
- Rohan TE, Jain MG, Howe GR, Miller AB. Dietary folate consumption and breast cancer risk.2000; 92: 266-9.
- Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, et al. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women.2001; 12: 420-8.
- Willett WC.New York: Oxford University Press; 1998.
- Potischman N, Swanson CA, Coates RJ, Gammon MD, Brogan DR, Curtin J, et al. Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer.1999; 82: 315-21.
- Nacci A, Dallan I, Bruschini L, Traino AC, Panicucci E, Bruschini P, et al. Plasma homocysteine, folate, and vitamin B12 levels in patients with laryngeal cancer.2008; 134: 1328-33.
- Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies.2008; 42: 69-81.
- Dahlin AM, Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Palmqvist R. Plasma vitamin B12 concentrations and the risk of colorectal cancer: a nested case-referent study.2008; 122: 2057-61.
- Friso S, Sang Woon C. The potential cocarcinogenic effect of vitamin B12.2005; 43: 1158-63.
- Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma.1993; 85: 875-84.
- Sofic A, Sehovic N, Beslic S, Prnjavorac B, Bilalovic N, Caluk J, et al. MR rectum imaging with ultra sound gel as instrumental contrast media in tubulovillous adenoma.2008; 42: 136-42.
- Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P, Walker AM. A case-control study of diet and cancer of the pancreas.1991; 134: 167-79.
- Graham S, Hellmann R, Marshall J, Freudenheim J, Vena J, Swanson M, et al. Nutritional epidemiology of postmenopausal breast cancer in western New York.1991; 134: 552-66.
- Iscovich JM, Iscovich RB, Howe G, Shiboski S, Kaldor JM. A case-control study of diet and breast cancer in Argentina.1989; 44: 770-6.
- Osterhues A, Holzgreve W, Michels KB. Shall we put the world on folate?2009; 19: 959-61.
- Ulrich CM, Potter JD. Folate and cancer: timing is everything.2007; 297: 2408-9.
- Shane B. Folate fortification: enough already?2003; 77: 8-9.
- Kalmbach RD, Choumenkovitch SF, Troen AM, D'Agostino R, Jacques PF, Selhub J. Circulating folic acid in plasma: relation to folic acid fortification.2008; 88: 763-8.
Language: English
Page range: 79 - 85
Published on: May 3, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2010 Nadja Plazar, Mihaela Jurdana, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.